axicabtagene ciloleucel
gilead sciences,daiichi sankyo
['axi-cel']
interesting follow-up presentation at #asco22 on outcomes of axi-cel by race and ethnicity after this legendary plenary question at #ash21: 
Hematology/oncology fellow. #lymsm & #mmsm outcomes researcher. Physician-publisher & founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????